Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CytImmune Sciences Inc.

www.cytimmune.com

Latest From CytImmune Sciences Inc.

Peptineo LLC

Delivering the right drugs to the right place at the right time has always been a challenge for the biopharmaceutical industry. Peptineo LLC aims to meet that challenge by developing and commercializing nanoscale technologies and materials for drug delivery and drug discovery. Its aim is to improve the delivery of drugs in development, extend the life cycle of marketed drugs, and repurpose existing or failed compounds.

BioPharmaceutical

Siva Therapeutics Inc.

Siva Therapeutics Inc. aims to destroy skin cancer cells from within by using its SivaRods, gold nanoparticles that combine with near-infrared light to create precisely targeted hyperthermia that destroys tumors with minimal collateral damage.

Medical Device

DEALS ROUND-UP: M&A and partnering 1-28 December

As companies flurried to clinch deals by the end of the year, a number of significant agreements were signed or completed last December.

Metabolic Disorders Infectious Diseases
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CytImmune Sciences Inc.
  • Senior Management
  • Larry Tamarkin, Pres. & CEO
  • Contact Info
  • CytImmune Sciences Inc.
    Phone: (301) 445-4220
    8075 Greenmead Dr.
    College Park, MD 20740-4003
    USA
UsernamePublicRestriction

Register